دورية أكاديمية

Final results of a phase I trial of HERV-E TCR transduced T cells for the treatment of HLA-A*11 patients with metastatic clear cell renal cell carcinoma (mccRCC).

التفاصيل البيبلوغرافية
العنوان: Final results of a phase I trial of HERV-E TCR transduced T cells for the treatment of HLA-A*11 patients with metastatic clear cell renal cell carcinoma (mccRCC).
المؤلفون: Nadal, Rosa, Barisic, Stefan, Scurti, Gina M., Cherkasova, Elena, Chen, Long, Wood, Kristen, Highfill, Steven L., Wells, Brian, Aue, Georg, Shalabi, Reem, Hughes, Thomas E., Tian, Xin, Xu, Yifei, Malayeri, Ashkan A., Reger, Robert N., Nishimura, Michael I., Childs, Richard W.
المصدر: Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p435-435, 140p
قاعدة البيانات: Supplemental Index
الوصف
تدمد:0732183X
DOI:10.1200/JCO.2024.42.4_suppl.435